BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 23329010)

  • 1. Compound heterozygosity involving Antithrombin Cambridge II (p.Ala416Ser) in antithrombin deficiency.
    Águila S; Martínez-Martínez I; Collado M; Llamas P; Antón AI; Martínez-Redondo C; Padilla J; Miñano A; de la Morena-Barrio ME; Garcia-Avello Á; Vicente V; Corral J
    Thromb Haemost; 2013 Mar; 109(3):556-8. PubMed ID: 23329010
    [No Abstract]   [Full Text] [Related]  

  • 2. [Antithrombin deficiency due to heterozygous antithrombin gene mutation and a pedigree study].
    Ye X; Feng Y; Jin PP; Zhou XH; Ding QL; Wang XF
    Zhonghua Xue Ye Xue Za Zhi; 2007 Sep; 28(9):587-9. PubMed ID: 18246812
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Report of a novel kindred with antithrombin heparin-binding site variant (47 Arg to His): demand for an automated progressive antithrombin assay to detect molecular variants with low thrombotic risk.
    Rossi E; Chiusolo P; Za T; Marietti S; Ciminello A; Leone G; De Stefano V
    Thromb Haemost; 2007 Sep; 98(3):695-7. PubMed ID: 17849067
    [No Abstract]   [Full Text] [Related]  

  • 4. Antithrombin Rybnik: a new point mutation (nt 683 G>T) associated with type I antithrombin deficiency in a patient with venous thromboembolism and recurrent superficial venous thrombosis.
    Szymańska M; Alhenc-Gelas M; Undas A
    Blood Coagul Fibrinolysis; 2013 Jul; 24(5):579-80. PubMed ID: 23807486
    [No Abstract]   [Full Text] [Related]  

  • 5. [Advances in the molecular biological study of hereditary antithrombin III deficiency].
    Chui H; Wang H
    Zhonghua Xue Ye Xue Za Zhi; 1998 Mar; 19(3):162-4. PubMed ID: 11243148
    [No Abstract]   [Full Text] [Related]  

  • 6. A novel mutation of antithrombin deficiency in six family siblings and the clinical combat.
    Nadir Y; Hoffman R; Corral J; Barak Y; Hasin T; Keren-Politansky A; Brenner B
    Thromb Haemost; 2015 Oct; 114(4):859-61. PubMed ID: 26177694
    [No Abstract]   [Full Text] [Related]  

  • 7. Genetic analysis should be included in clinical practice when screening for antithrombin deficiency.
    Zeng W; Tang L; Jian XR; Li YQ; Guo T; Wang QY; Liu H; Wu YY; Cheng ZP; Hu B; Lu X; Yu JM; Deng J; Wang HF; Sun CY; Yang Y; Hu Y
    Thromb Haemost; 2015 Feb; 113(2):262-71. PubMed ID: 25298121
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular bases of antithrombin deficiency: twenty-two novel mutations in the antithrombin gene.
    Picard V; Nowak-Göttl U; Biron-Andreani C; Fouassier M; Frere C; Goualt-Heilman M; de Maistre E; Regina S; Rugeri L; Ternisien C; Trichet C; Vergnes C; Aiach M; Alhenc-Gelas M
    Hum Mutat; 2006 Jun; 27(6):600. PubMed ID: 16705712
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antithrombin-III (AT-III) deficiency spanning four generations.
    Mazza JJ; Mueller-Rizner NJ; Roberts RC
    Thromb Haemost; 1991 Dec; 66(6):737-8. PubMed ID: 1796421
    [No Abstract]   [Full Text] [Related]  

  • 10. Antithrombin gene mutation 5356-5364*delCTT with type I deficiency and early-onset thrombophilia and a brief review of the antithrombin alpha-helix D molecular pathology.
    Steiner M; Steiner B; Rolfs A; Wangnick M; Burstein C; Freund M; Schuff-Werner P
    Ann Hematol; 2005 Jan; 84(1):56-8. PubMed ID: 15309521
    [No Abstract]   [Full Text] [Related]  

  • 11. Arterial and venous thrombosis and prothrombotic fibrin clot phenotype in a Polish family with type 1 antithrombin deficiency (antithrombin Krakow).
    Celinska-Lowenhoff M; Iwaniec T; Alhenc-Gelas M; Musial J; Undas A
    Thromb Haemost; 2011 Aug; 106(2):379-81. PubMed ID: 21655678
    [No Abstract]   [Full Text] [Related]  

  • 12. Antithrombin Dublin (p.Val30Glu): a relatively common variant with moderate thrombosis risk of causing transient antithrombin deficiency.
    Navarro-Fernández J; de la Morena-Barrio ME; Padilla J; Miñano A; Bohdan N; Águila S; Martínez-Martínez I; Sevivas TS; de Cos C; Fernández-Mosteirín N; Llamas P; Asenjo S; Medina P; Souto JC; Overvad K; Kristensen SR; Corral J; Vicente V
    Thromb Haemost; 2016 Jul; 116(1):146-54. PubMed ID: 27098529
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antithrombin Nagasaki (Ser 116 to Pro): a rare antithrombin variant with abnormal heparin binding presenting during pregnancy.
    O'Ddonnell JS; Hinkson L; McCarthy A; Manning R; Khan A; Laffan MA
    Blood Coagul Fibrinolysis; 2006 Apr; 17(3):217-20. PubMed ID: 16575261
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SERPINC1 gene mutations in antithrombin deficiency.
    Mulder R; Croles FN; Mulder AB; Huntington JA; Meijer K; Lukens MV
    Br J Haematol; 2017 Jul; 178(2):279-285. PubMed ID: 28317092
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antithrombin Cambridge II mutation as a risk factor to develop cerebral venous thrombosis.
    Barba P; Santamaría A; Tirado I; Martí E; Fontcuberta J
    Thromb Haemost; 2008 Feb; 99(2):443-4. PubMed ID: 18278198
    [No Abstract]   [Full Text] [Related]  

  • 16. Regulatory regions of SERPINC1 gene: identification of the first mutation associated with antithrombin deficiency.
    de la Morena-Barrio ME; Antón AI; Martínez-Martínez I; Padilla J; Miñano A; Navarro-Fernández J; Águila S; López MF; Fontcuberta J; Vicente V; Corral J
    Thromb Haemost; 2012 Mar; 107(3):430-7. PubMed ID: 22234719
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antithrombin deficiency in three Japanese families: one novel and two reported point mutations in the antithrombin gene.
    Maruyama K; Morishita E; Karato M; Kadono T; Sekiya A; Goto Y; Sato T; Nomoto H; Omi W; Tsuzura S; Imai H; Asakura H; Ohtake S; Nakao S
    Thromb Res; 2013 Aug; 132(2):e118-23. PubMed ID: 23809926
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genotype-phenotype gradient of SERPINC1 variants in a single family reveals a severe compound antithrombin deficiency in a dead embryo.
    Bravo-Pérez C; de la Morena-Barrio ME; Palomo A; Entrena L; de la Morena-Barrio B; Padilla J; Miñano A; Navarro E; Cifuentes R; Corral J; Vicente V
    Br J Haematol; 2020 Oct; 191(1):e32-e35. PubMed ID: 32686144
    [No Abstract]   [Full Text] [Related]  

  • 19. Creation of an additional glycosylation site as a mechanism for type I antithrombin deficiency.
    Fitches AC; Lewandowski K; Olds RJ
    Thromb Haemost; 2001 Oct; 86(4):1023-7. PubMed ID: 11686319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. c.1058C>T variant in the SERPINC1 gene is pathogenic for antithrombin deficiency.
    Kumar R; Dawson JE; Chan AK; Forman-Kay JD; Kahr WH; Williams S
    Br J Haematol; 2015 Jul; 170(1):123-5. PubMed ID: 25522812
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.